320 related articles for article (PubMed ID: 28380264)
1. Heat shock protein 70 potentiates interferon alpha production by plasmacytoid dendritic cells: relevance for cutaneous lupus and vitiligo pathogenesis.
Jacquemin C; Rambert J; Guillet S; Thiolat D; Boukhedouni N; Doutre MS; Darrigade AS; Ezzedine K; Blanco P; Taieb A; Boniface K; Seneschal J
Br J Dermatol; 2017 Nov; 177(5):1367-1375. PubMed ID: 28380264
[TBL] [Abstract][Full Text] [Related]
2. Interferon-α stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus.
Zahn S; Rehkämper C; Ferring-Schmitt S; Bieber T; Tüting T; Wenzel J
Br J Dermatol; 2011 Nov; 165(5):1118-23. PubMed ID: 21711324
[TBL] [Abstract][Full Text] [Related]
3. IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
Khoryati L; Augusto JF; Shipley E; Contin-Bordes C; Douchet I; Mitrovic S; Truchetet ME; Lazaro E; Duffau P; Couzi L; Jacquemin C; Barnetche T; Vacher P; Schaeverbeke T; Blanco P; Richez C;
Arthritis Rheumatol; 2016 Sep; 68(9):2221-31. PubMed ID: 26991804
[TBL] [Abstract][Full Text] [Related]
4. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S
Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537
[TBL] [Abstract][Full Text] [Related]
5. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
[TBL] [Abstract][Full Text] [Related]
6. Effect of
Gardet A; Pellerin A; McCarl CA; Diwanji R; Wang W; Donaldson D; Franchimont N; Werth VP; Rabah D
Front Immunol; 2019; 10():275. PubMed ID: 30846987
[No Abstract] [Full Text] [Related]
7. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus.
Kwok SK; Lee JY; Park SH; Cho ML; Min SY; Park SH; Kim HY; Cho YG
Arthritis Res Ther; 2008; 10(2):R29. PubMed ID: 18321389
[TBL] [Abstract][Full Text] [Related]
8. Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus.
Meller S; Winterberg F; Gilliet M; Müller A; Lauceviciute I; Rieker J; Neumann NJ; Kubitza R; Gombert M; Bünemann E; Wiesner U; Franken-Kunkel P; Kanzler H; Dieu-Nosjean MC; Amara A; Ruzicka T; Lehmann P; Zlotnik A; Homey B
Arthritis Rheum; 2005 May; 52(5):1504-16. PubMed ID: 15880822
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus.
Sacre K; Criswell LA; McCune JM
Arthritis Res Ther; 2012 Jun; 14(3):R155. PubMed ID: 22734582
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid Dendritic Cells Are Not Major Producers of Type 1 IFN in Cutaneous Lupus: An In-Depth Immunoprofile of Subacute and Discoid Lupus.
Vazquez T; Patel J; Kodali N; Diaz D; Bashir MM; Chin F; Keyes E; Sharma M; Sprow G; Grinnell M; Dan J; Werth VP
J Invest Dermatol; 2024 Jun; 144(6):1262-1272.e7. PubMed ID: 38086428
[TBL] [Abstract][Full Text] [Related]
11. Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells.
Wang J; Lau KY; Jung J; Ravindran P; Barrat FJ
Eur J Immunol; 2014 Apr; 44(4):1130-6. PubMed ID: 24375473
[TBL] [Abstract][Full Text] [Related]
12. Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα.
Chao Y; Kaliaperumal N; Chretien AS; Tang S; Lee B; Poidinger M; Fairhurst AM; Connolly JE
J Leukoc Biol; 2014 Dec; 96(6):1037-46. PubMed ID: 25170117
[TBL] [Abstract][Full Text] [Related]
13. Plasmacytoid dendritic cell heterogeneity is defined by CXCL10 expression following TLR7 stimulation.
Marsman C; Lafouresse F; Liao Y; Baldwin TM; Mielke LA; Hu Y; Mack M; Hertzog PJ; de Graaf CA; Shi W; Groom JR
Immunol Cell Biol; 2018 Nov; 96(10):1083-1094. PubMed ID: 29870118
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus.
McNiff JM; Kaplan DH
J Cutan Pathol; 2008 May; 35(5):452-6. PubMed ID: 18005168
[TBL] [Abstract][Full Text] [Related]
15. The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets.
Wenzel J; Zahn S; Mikus S; Wiechert A; Bieber T; Tüting T
Br J Dermatol; 2007 Oct; 157(4):752-7. PubMed ID: 17714558
[TBL] [Abstract][Full Text] [Related]
16. Siglec-1-positive plasmacytoid dendritic cells (pDCs) in human peripheral blood: A semi-mature and myeloid-like subset imbalanced during protective and autoimmune responses.
Wilhelm TR; Taddeo A; Winter O; Schulz AR; Mälzer JN; Domingo C; Biesen R; Alexander T; Thiel A; Radbruch A; Hiepe F; Gerl V
Clin Immunol; 2016 Feb; 163():42-51. PubMed ID: 26674280
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of guanylate binding protein-1 in lesional skin of patients with cutaneous lupus erythematosus.
Naschberger E; Wenzel J; Kretz CC; Herrmann M; Stürzl M; Kuhn A
Exp Dermatol; 2011 Feb; 20(2):102-6. PubMed ID: 21121962
[TBL] [Abstract][Full Text] [Related]
18. S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells.
Dillmann C; Ringel C; Ringleb J; Mora J; Olesch C; Fink AF; Roberts E; Brüne B; Weigert A
J Immunol; 2016 Feb; 196(4):1579-90. PubMed ID: 26783340
[TBL] [Abstract][Full Text] [Related]
19. Culture supernatants of oral cancer cells induce impaired IFN-α production of pDCs partly through the down-regulation of TLR-9 expression.
Han N; Zhang Z; Jv H; Hu J; Ruan M; Zhang C
Arch Oral Biol; 2018 Sep; 93():141-148. PubMed ID: 29913322
[TBL] [Abstract][Full Text] [Related]
20. The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus.
Cho YM; Furie R
Immunotherapy; 2024 Jan; 16(1):15-20. PubMed ID: 37877249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
